trpm8 antagonist Search Results


trpm8 antagonist 2  (MuseChem Chemicals)
N/A
TRPM8 antagonist 2 (Cat.No:I019762) is a chemical compound known for its inhibitory effects on the transient receptor potential melastatin 8 (TRPM8) channel. TRPM8 is involved in thermoregulation and nociception. TRPM8 antagonist 2 has potential applications
   Buy from Supplier
trpm8 antagonist 4 prodrug  (TargetMol)
N/A
   Buy from Supplier
non-selective trpm8 antagonist  (MultiTarget Pharmaceuticals)
90
MultiTarget Pharmaceuticals non-selective trpm8 antagonist
Model <t>TRPM8</t> agonists (most widely used in pharmacological studies).
Non Selective Trpm8 Antagonist, supplied by MultiTarget Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trpm8+antagonist/non+selective+trpm8+antagonist/pmc08395166-389-1-5
Average 90 stars, based on 1 article reviews
non-selective trpm8 antagonist - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
trpm8 antagonists  (Weyer GmbH)
90
Weyer GmbH trpm8 antagonists
Model <t>TRPM8</t> agonists (most widely used in pharmacological studies).
Trpm8 Antagonists, supplied by Weyer GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trpm8+antagonist/trpm8+antagonists/pm36657655-113-42-59
Average 90 stars, based on 1 article reviews
trpm8 antagonists - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
trpv1/ trpm8 antagonist bctc  (Biomol GmbH)
90
Biomol GmbH trpv1/ trpm8 antagonist bctc
Model <t>TRPM8</t> agonists (most widely used in pharmacological studies).
Trpv1/ Trpm8 Antagonist Bctc, supplied by Biomol GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trpm8+antagonist/trpv1++trpm8+antagonist+bctc/pm26928772-28-28-32
Average 90 stars, based on 1 article reviews
trpv1/ trpm8 antagonist bctc - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
trpm8 antagonists  (GW Pharmaceuticals)
90
GW Pharmaceuticals trpm8 antagonists
Genes included in the proposed NGS panel of persisting pain, combined from three subsets included on different bases.
Trpm8 Antagonists, supplied by GW Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trpm8+antagonist/trpm8+antagonists/pmc06156278-250-7-10
Average 90 stars, based on 1 article reviews
trpm8 antagonists - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
small molecule trpm8 antagonists  (Pain Therapeutics)
90
Pain Therapeutics small molecule trpm8 antagonists
Genes included in the proposed NGS panel of persisting pain, combined from three subsets included on different bases.
Small Molecule Trpm8 Antagonists, supplied by Pain Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trpm8+antagonist/small+molecule+trpm8+antagonists/pm23411075-9-4-15
Average 90 stars, based on 1 article reviews
small molecule trpm8 antagonists - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
trpm8 antagonists  (Bayer HealthCare Pharmaceuticals Inc)
90
Bayer HealthCare Pharmaceuticals Inc trpm8 antagonists
Genes included in the proposed NGS panel of persisting pain, combined from three subsets included on different bases.
Trpm8 Antagonists, supplied by Bayer HealthCare Pharmaceuticals Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trpm8+antagonist/trpm8+antagonists/pm23500195-290-15-2
Average 90 stars, based on 1 article reviews
trpm8 antagonists - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
trpm8 antagonist 2  (TargetMol)
N/A
   Buy from Supplier
trpm8 antagonist 2  (MedChemExpress)
N/A
TRPM8 antagonist 2 is a potent and selective TRPM8 antagonist, with an IC50 of 0.2 nM, used in the research of neuropathic pain syndromes.
   Buy from Supplier
trpm8 antagonist 2  (Biosynth Carbosynth)
N/A
   Buy from Supplier
trpm8 antagonist 3  (MedChemExpress)
N/A
TRPM8 antagonist 3 is a novel TRPM8 blocker with an IC50 value of 11 nM.
   Buy from Supplier

Image Search Results


Model TRPM8 agonists (most widely used in pharmacological studies).

Journal: International Journal of Molecular Sciences

Article Title: TRPM8 Channels: Advances in Structural Studies and Pharmacological Modulation

doi: 10.3390/ijms22168502

Figure Lengend Snippet: Model TRPM8 agonists (most widely used in pharmacological studies).

Article Snippet: This non-selective TRPM8 antagonist, with multitarget activity, including TRPV1, TRPV2 and TRPA1 antagonist activity [ ], is under different clinical studies.

Techniques:

( A ) Cartoon representation of the full TRPM8 tetramer (based on the structure of pdb code 6O77) . Each subunit is colored differently. ( B ) TM region of two subunits of TRPM8 showing the swapped-domain arrangement. Software for creating images [ , ].

Journal: International Journal of Molecular Sciences

Article Title: TRPM8 Channels: Advances in Structural Studies and Pharmacological Modulation

doi: 10.3390/ijms22168502

Figure Lengend Snippet: ( A ) Cartoon representation of the full TRPM8 tetramer (based on the structure of pdb code 6O77) . Each subunit is colored differently. ( B ) TM region of two subunits of TRPM8 showing the swapped-domain arrangement. Software for creating images [ , ].

Article Snippet: This non-selective TRPM8 antagonist, with multitarget activity, including TRPV1, TRPV2 and TRPA1 antagonist activity [ ], is under different clinical studies.

Techniques: Software

Representation of TRPM8 ligands within the receptor binding site (grey). ( A ) fa TRPM8-WS-12 (green) (pdb code 6NR2), ( B ) fa TRPM8-Icilin (cyan) (pdb code 6NR3), ( C ) pm TRPM8-AMTB (pink) (pdb code 6O6R), ( D ) pm TRPM8 TC-I 2014 (yellow) (pdb code 6O72). Residues discussed in the test are labeled. Ca 2+ is depicted as a green sphere, and hydrogen bonds as dashed grey lines. For clarity, only polar hydrogens are shown. Software for creating images .

Journal: International Journal of Molecular Sciences

Article Title: TRPM8 Channels: Advances in Structural Studies and Pharmacological Modulation

doi: 10.3390/ijms22168502

Figure Lengend Snippet: Representation of TRPM8 ligands within the receptor binding site (grey). ( A ) fa TRPM8-WS-12 (green) (pdb code 6NR2), ( B ) fa TRPM8-Icilin (cyan) (pdb code 6NR3), ( C ) pm TRPM8-AMTB (pink) (pdb code 6O6R), ( D ) pm TRPM8 TC-I 2014 (yellow) (pdb code 6O72). Residues discussed in the test are labeled. Ca 2+ is depicted as a green sphere, and hydrogen bonds as dashed grey lines. For clarity, only polar hydrogens are shown. Software for creating images .

Article Snippet: This non-selective TRPM8 antagonist, with multitarget activity, including TRPV1, TRPV2 and TRPA1 antagonist activity [ ], is under different clinical studies.

Techniques: Binding Assay, Labeling, Software

Main TRPM8 agonists: selected compounds from new chemotypes recently described.

Journal: International Journal of Molecular Sciences

Article Title: TRPM8 Channels: Advances in Structural Studies and Pharmacological Modulation

doi: 10.3390/ijms22168502

Figure Lengend Snippet: Main TRPM8 agonists: selected compounds from new chemotypes recently described.

Article Snippet: This non-selective TRPM8 antagonist, with multitarget activity, including TRPV1, TRPV2 and TRPA1 antagonist activity [ ], is under different clinical studies.

Techniques:

Selected examples of newly described families of TRPM8 agonists.

Journal: International Journal of Molecular Sciences

Article Title: TRPM8 Channels: Advances in Structural Studies and Pharmacological Modulation

doi: 10.3390/ijms22168502

Figure Lengend Snippet: Selected examples of newly described families of TRPM8 agonists.

Article Snippet: This non-selective TRPM8 antagonist, with multitarget activity, including TRPV1, TRPV2 and TRPA1 antagonist activity [ ], is under different clinical studies.

Techniques:

Novel TRPM8 antagonists derived from natural sources and pharmaceutical companies.

Journal: International Journal of Molecular Sciences

Article Title: TRPM8 Channels: Advances in Structural Studies and Pharmacological Modulation

doi: 10.3390/ijms22168502

Figure Lengend Snippet: Novel TRPM8 antagonists derived from natural sources and pharmaceutical companies.

Article Snippet: This non-selective TRPM8 antagonist, with multitarget activity, including TRPV1, TRPV2 and TRPA1 antagonist activity [ ], is under different clinical studies.

Techniques: Derivative Assay

Representative examples of newly described families of TRPM8 antagonists.

Journal: International Journal of Molecular Sciences

Article Title: TRPM8 Channels: Advances in Structural Studies and Pharmacological Modulation

doi: 10.3390/ijms22168502

Figure Lengend Snippet: Representative examples of newly described families of TRPM8 antagonists.

Article Snippet: This non-selective TRPM8 antagonist, with multitarget activity, including TRPV1, TRPV2 and TRPA1 antagonist activity [ ], is under different clinical studies.

Techniques: Patch Clamp, In Vivo, Activity Assay

Recently published TRPM8 antagonists from academic groups.

Journal: International Journal of Molecular Sciences

Article Title: TRPM8 Channels: Advances in Structural Studies and Pharmacological Modulation

doi: 10.3390/ijms22168502

Figure Lengend Snippet: Recently published TRPM8 antagonists from academic groups.

Article Snippet: This non-selective TRPM8 antagonist, with multitarget activity, including TRPV1, TRPV2 and TRPA1 antagonist activity [ ], is under different clinical studies.

Techniques:

Selection of main clinical studies on TRPM8-targeted therapies and diagnosis probes a .

Journal: International Journal of Molecular Sciences

Article Title: TRPM8 Channels: Advances in Structural Studies and Pharmacological Modulation

doi: 10.3390/ijms22168502

Figure Lengend Snippet: Selection of main clinical studies on TRPM8-targeted therapies and diagnosis probes a .

Article Snippet: This non-selective TRPM8 antagonist, with multitarget activity, including TRPV1, TRPV2 and TRPA1 antagonist activity [ ], is under different clinical studies.

Techniques: Selection, Biomarker Discovery

Genes included in the proposed NGS panel of persisting pain, combined from three subsets included on different bases.

Journal: Frontiers in Pharmacology

Article Title: Development of an AmpliSeq TM Panel for Next-Generation Sequencing of a Set of Genetic Predictors of Persisting Pain

doi: 10.3389/fphar.2018.01008

Figure Lengend Snippet: Genes included in the proposed NGS panel of persisting pain, combined from three subsets included on different bases.

Article Snippet: TRPM8 , Phase II , Cannabidivarin , TRPM8 Antagonists , GW Pharmaceuticals.

Techniques: Binding Assay, Derivative Assay

A list of coding human variants in the 77 putative chronic pain genes, found in the present random sample of 72 subjects of Caucasian ethnicity, for which clinical associations have been reported.

Journal: Frontiers in Pharmacology

Article Title: Development of an AmpliSeq TM Panel for Next-Generation Sequencing of a Set of Genetic Predictors of Persisting Pain

doi: 10.3389/fphar.2018.01008

Figure Lengend Snippet: A list of coding human variants in the 77 putative chronic pain genes, found in the present random sample of 72 subjects of Caucasian ethnicity, for which clinical associations have been reported.

Article Snippet: TRPM8 , Phase II , Cannabidivarin , TRPM8 Antagonists , GW Pharmaceuticals.

Techniques: Variant Assay

Current targeting of the genes included in the proposed NGS panel of persisting pain by novel drugs that are currently under active clinical development and include analgesia as the main clinical target or at least as one of the intended clinical indication.

Journal: Frontiers in Pharmacology

Article Title: Development of an AmpliSeq TM Panel for Next-Generation Sequencing of a Set of Genetic Predictors of Persisting Pain

doi: 10.3389/fphar.2018.01008

Figure Lengend Snippet: Current targeting of the genes included in the proposed NGS panel of persisting pain by novel drugs that are currently under active clinical development and include analgesia as the main clinical target or at least as one of the intended clinical indication.

Article Snippet: TRPM8 , Phase II , Cannabidivarin , TRPM8 Antagonists , GW Pharmaceuticals.

Techniques: Transduction, Expressing